Andrew E. Teschendorff mainly investigates DNA methylation, Epigenetics, Bioinformatics, Genetics and Breast cancer. His DNA methylation study incorporates themes from Methylation, Computational biology and Data mining. The concepts of his Computational biology study are interwoven with issues in Human genome and Genotype.
The Epigenetics study combines topics in areas such as Cellular differentiation, Epigenomics, Internal medicine, Epigenesis and Colorectal cancer. His Bioinformatics study combines topics from a wide range of disciplines, such as Type 1 diabetes and Diabetic nephropathy. His studies in Breast cancer integrate themes in fields like Comparative genomic hybridization and Gene expression profiling.
Andrew E. Teschendorff mostly deals with DNA methylation, Epigenetics, Computational biology, Genetics and Cancer. His biological study spans a wide range of topics, including Cancer research and Methylation. Within one scientific family, Andrew E. Teschendorff focuses on topics pertaining to Carcinogenesis under Epigenetics, and may sometimes address concerns connected to Molecular biology.
His work deals with themes such as Interaction network, Cancer stem cell, Transcriptome and Genetic association, which intersect with Computational biology. As part of the same scientific family, Andrew E. Teschendorff usually focuses on Cancer, concentrating on Transcription factor and intersecting with RNA-Seq. His Breast cancer study deals with Oncology intersecting with Immunology.
His primary areas of study are DNA methylation, Computational biology, Epigenetics, CpG site and Epigenome. His research integrates issues of Cancer research and Cell type in his study of DNA methylation. Andrew E. Teschendorff works mostly in the field of Cancer research, limiting it down to concerns involving Cancer and, occasionally, Buccal swab.
His Computational biology research includes themes of Epigenomics, RNA-Seq, Genetic association and Regulation of gene expression. His research on Epigenetics concerns the broader Genetics. His CpG site research includes elements of Methylation, Genome-wide association study, Selection, Lung cancer and Peripheral blood.
His scientific interests lie mostly in DNA methylation, Computational biology, CpG site, Epigenetics and Epigenome. His study brings together the fields of Oncology and DNA methylation. His work in Computational biology addresses issues such as Epigenomics, which are connected to fields such as Epigenome editing, Chromatin and Cell type specific.
His CpG site study integrates concerns from other disciplines, such as Genome-wide association study, Methylation, Medical genetics, Cell type and dNaM. His Epigenetics research is classified as research in Genetics. His work in Epigenome addresses subjects such as Cancer, which are connected to disciplines such as Bioinformatics and Exposome.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data
Andrew E. Teschendorff;Francesco Marabita;Matthias Lechner;Thomas Bartlett.
Bioinformatics (2013)
Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
Sohrab P. Shah;Ryan D. Morin;Jaswinder Khattra;Leah Prentice.
Nature (2009)
MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype
Cherie Blenkiron;Leonard D Goldstein;Natalie P Thorne;Inmaculada Spiteri.
Genome Biology (2007)
Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer
Andrew E. Teschendorff;Usha Menon;Aleksandra Gentry-Maharaj;Susan J. Ramus.
Genome Research (2010)
An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer
Andrew E Teschendorff;Ahmad Miremadi;Sarah E Pinder;Ian O Ellis.
Genome Biology (2007)
ChAMP: 450k Chip Analysis Methylation Pipeline
Tiffany J. Morris;Lee M. Butcher;Andrew Feber;Andrew E. Teschendorff.
Bioinformatics (2014)
Data integration in the era of omics: current and future challenges.
David Gomez-Cabrero;Imad Abugessaisa;Dieter Maier;Andrew E. Teschendorff.
BMC Systems Biology (2014)
High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer.
Suet F Chin;Andrew E Teschendorff;John C Marioni;Yanzhong Wang.
Genome Biology (2007)
Allele-Specific Up-Regulation of FGFR2 Increases Susceptibility to Breast Cancer
Kerstin B Meyer;Ana-Teresa Maia;Martin O'Reilly;Andrew E Teschendorff.
PLOS Biology (2008)
An epigenetic signature in peripheral blood predicts active ovarian cancer.
Andrew E. Teschendorff;Usha Menon;Aleksandra Gentry-Maharaj;Susan J. Ramus.
PLOS ONE (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University College London
University of Cambridge
University of New South Wales
University College London
University College London
University of Nottingham
University of Cambridge
Université Catholique de Louvain
University of Bristol
University College London
Aalto University
City University of New York
Alibaba Group (China)
Northeastern University
Karolinska Institute
National Institute of Advanced Industrial Science and Technology
University of Basel
Hannover Medical School
US Forest Service
Nihon University
Universidade de São Paulo
University of Córdoba
The University of Texas at Austin
Brigham and Women's Hospital
Lancaster University
Pepperdine University